Entering text into the input field will update the search result below

EU approves Takeda's takeover of Shire with divestment condition

  • The European Commission approves Takeda's (OTCPK:TKPHF, TKPYY) $62B takeover of Shire (NASDAQ:SHPG), subject to the divestment of a Shire drug aimed at treating inflammatory bowel disease currently in development.
  • The EC says Takeda agreed to the sale in order to ensure that the drug in Shire’s pipeline would continue to the market, where it is expected to compete with Entyvio, Takeda’s biggest-selling drug.
  • Takeda already has secured unconditional clearance from regulators in the U.S., Japan, China and Brazil.
  • Also: Advisory firms back Takeda's Shire buy (Nov. 20)

Recommended For You

About TKPHF Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TKPHF--
Takeda Pharmaceutical Company Limited